Intrinsiqs

Is Utah Medical Products, Inc. overvalued?

Utah Medical Products, Inc. (UTMD) looks overvalued — trading about 27% above its fair value.

Overvalued
Current price $74.49 Fair value $54.73
Price
$74.49
Fair value
$54.73
Current P/E
22.0
Normal P/E
16.2
Market cap
$237.2M
Dividend yield
1.7%
Return on equity
8.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares UTMD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated